Japan Biosimilar- Active Players In Quest of a Specialty & Niche BS space - 0 views
-
aarkstore2015 on 08 Mar 17Encouraging Uptake of Filgrastim BS and Lantus BS in 2015 in Japan is indicative of Japan being a key important market after the EU for growth of Biosimilar players in the next five years. Biosimilar of Complex mAb structure is an opportunity of cumulative market size of 300b in the next three years in Japan.